Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Regeneron
Health
Cancer
Mental Health
Reproductive Health
Obesity
Topics

Advertisement

Regeneron

Share

Top Latest Popular

Regeneron cuts White House pricing deal, offers new gene therapy for free Pharmaceutical Technology 11:22 Fri, 24 Apr

Pharmaceutical Technology 11:22 Fri, 24 Apr

Hearing Loss Biotech

Regeneron presses amgen for eylea antitrust damages evidence Bloomberg Law 21:29 Thu, 30 Apr

Bloomberg Law 21:29 Thu, 30 Apr

STAT Plus: Trump celebrates closing first round of drug pricing deals, promises more ahead STAT 21:08 Thu, 23 Apr

STAT 21:08 Thu, 23 Apr

Advertisement

Regeneron Q1 earnings top, sales up on Dupixent & eylea HD strength Zacks 18:36 Wed, 29 Apr

Zacks 18:36 Wed, 29 Apr

CRISPR genome editing and the future of down syndrome treatment Reason 16:43 Thu, 30 Apr

Reason 16:43 Thu, 30 Apr

Alzheimer's CRISPR/Gene Editing

Saudi Arabia competes at Regeneron isef 2026 with 40 students Riyadh Daily 20h

Riyadh Daily 20h

Advertisement

Advertisement

Latest

Yesterday

Saudi Arabia Competes at Regeneron ISEF 2026 with 40 Students Riyadh Daily 19:34 Tue, 12 May

Monday

Spotlight On: Biosimilar Litigations - May 2026 JD Supra 19:16 Mon, 11 May

Friday

Assessing Regeneron (REGN) After Recent Share Price Weakness And Strong Valuation Signals Simply Wall St 22:59 Fri, 08 May

La Vega’s David Martinez to represent Waco at world’s largest pre-college stem fair KWTX 13:39 Fri, 08 May

Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years Regeneron Pharmaceuticals (Press Release) 12:07 Fri, 08 May

Is This Biotech Stock a Buy After a Groundbreaking Approval? The Motley Fool 09:01 Fri, 08 May

In the last month

Does Regeneron’s Gene Therapy Milestone and Buyback Shift the Bull Case For Regeneron Pharmaceuticals (REGN)? Simply Wall St 07:02 Wed, 06 May

Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality PR Newswire (Press Release) 14:09 Tue, 05 May

LIMERICK IN PHOTOS: Record-breaking year as over 20,000 take part in 2026 Great Limerick Run Limerick Post 13:37 Tue, 05 May

One More Iffy Trump Drug Deal CounterPunch 06:49 Mon, 04 May

Advertisement

Advertisement

Advertisement

Popular

Is this biotech stock a buy after a groundbreaking approval?

The Motley Fool 5d

Does Regeneron’s gene therapy milestone and buyback shift the bull case for Regeneron Pharmaceuticals (regn)?

Simply Wall St 7d

Regeneron presses amgen for eylea antitrust damages evidence

Bloomberg Law 21:29 Thu, 30 Apr

Regeneron Pharmaceuticals analysts cut their forecasts following Q1 earnings

Benzinga 17:47 Thu, 30 Apr

Regeneron Q1 2026 net income falls 10% to $727m

Pharmaceutical Technology 09:34 Thu, 30 Apr

Advertisement

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Cancer Cancer
- Infectious Diseases
- Mental Health
- Neurological Diseases
- Obesity Obesity
- Rare Diseases
- Reproductive Health